Universal Beteiligungs und Servicegesellschaft mbH Has $30.84 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Universal Beteiligungs und Servicegesellschaft mbH increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 410,634 shares of the company’s stock after acquiring an additional 17,335 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in GE HealthCare Technologies were worth $30,839,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of GE HealthCare Technologies by 4.2% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 159,882 shares of the company’s stock worth $11,842,000 after acquiring an additional 6,479 shares in the last quarter. Wedge Capital Management L L P NC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $26,859,000. Valicenti Advisory Services Inc. increased its stake in GE HealthCare Technologies by 22.6% during the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after purchasing an additional 12,550 shares in the last quarter. National Bank of Canada FI increased its stake in GE HealthCare Technologies by 133.3% during the 2nd quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock worth $66,640,000 after purchasing an additional 514,007 shares in the last quarter. Finally, Osaic Holdings Inc. raised its holdings in GE HealthCare Technologies by 18.1% during the 2nd quarter. Osaic Holdings Inc. now owns 224,869 shares of the company’s stock worth $16,674,000 after buying an additional 34,499 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC opened at $81.89 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The business’s 50-day simple moving average is $81.85 and its 200 day simple moving average is $77.17. The firm has a market capitalization of $37.30 billion, a PE ratio of 16.92, a PEG ratio of 2.45 and a beta of 1.08. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Citigroup increased their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Morgan Stanley upped their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their price target for the company from $73.00 to $77.00 in a research note on Thursday, January 15th. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 price target on shares of GE HealthCare Technologies in a report on Friday, January 9th. Finally, Barclays started coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective for the company. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $89.83.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.